Serum Institute, Bharat Biotech to begin trial of intranasal COVID 19 vaccine soon – minister

almost 5 years in nationalpost

NEW DELHI — Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, India’s health minister said on Sunday. Dr Harsh Vardhan said the late stage trial generally involves thousands of participants, sometimes 30,000 to 40,000. Of […]

Mentioned in this news
Share it on